Clinical experience with daptomycin in Europe: the first 2.5 years (Q34681219)

3 August 2017

Clinical experience with daptomycin in Europe: the first 2.5 years (English)

1 reference

3 August 2017

5

Juergen Loeffler

1 reference

3 August 2017

Armando Gonzalez-Ruiz

1

1 reference

3 August 2017

Andres Beiras-Fernandez

2

1 reference

3 August 2017

Hans Lehmkuhl

3

1 reference

3 August 2017

R Andrew Seaton

4

1 reference

3 August 2017

Ricardo L Chaves

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 January 2011

1 reference

Journal of Antimicrobial Chemotherapy

3 August 2017

1 reference

3 August 2017

66

1 reference

3 August 2017

4

1 reference

3 August 2017

912-919

1 reference

Daptomycin use in patients with cancer and neutropenia: data from a retrospective registry.

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

A potential role for daptomycin in enterococcal infections: what is the evidence?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Are glycopeptides still appropriate and convenient for empiric use?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Once-daily dosing in dogs optimizes daptomycin safety

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Daptomycin for the treatment of surgical site infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Potential genetic causes of heterogeneity of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

A better future for patients with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ528

Cubicin Outcomes Registry and Experience (CORE) methodology

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Daptomycin in the treatment of patients with infective endocarditis: experience from a registry

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Daptomycin in the treatment of bacteremia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

Clinical experience with daptomycin for the treatment of patients with osteomyelitis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058564

The Advantage of Bactericidal Drugs in the Treatment of Infection

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21393205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical outcomes with daptomycin: a post-marketing, real-world evaluation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21393205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JAC/DKQ528

1 reference

3 August 2017

1 reference

3 August 2017

1 reference